Home Blog Page 38

BCL2 Rearrangement Test: Follicular Lymphoma, Rearrangement Status, and FISH Result

Understand BCL2 rearrangement testing in follicular lymphoma, including IGH::BCL2, t(14;18), FISH results, negative tests, and how findings affect tumor classification.

A BCL2 rearrangement test looks for a structural change involving the BCL2 gene, most often the classic IGH::BCL2 fusion created by t(14;18)(q32;q21). This abnormality...

BCR-ABL1 Quantitative PCR Test: CML Monitoring, Molecular Response, and Transcript Level

Learn how BCR-ABL1 quantitative PCR monitors CML, including International Scale percentages, MMR, MR4/MR4.5, milestone timing, rising results, and undetectable transcripts.

The BCR-ABL1 quantitative PCR test is the main blood test used to monitor molecular response in chronic myeloid leukemia (CML). It measures the amount...

BCR-ABL1 Test: Chronic Myeloid Leukemia, Philadelphia Chromosome, and Molecular Diagnosis

Learn how BCR-ABL1 testing detects the Philadelphia chromosome in CML, how PCR, FISH, and karyotyping differ, and what positive or negative results mean.

A BCR-ABL1 test looks for the abnormal BCR::ABL1 fusion gene that defines chronic myeloid leukemia (CML) and can also occur in some acute leukemias....

Beta-2 Microglobulin Test for Myeloma: Staging, Prognosis, Tumor Burden, and Kidney Function

Learn how beta-2 microglobulin is used in multiple myeloma staging and prognosis, why kidney function changes the result, and how to interpret high levels.

A beta-2 microglobulin test measures a small protein in blood that is used as part of staging and prognosis in multiple myeloma. In myeloma,...

BTK Mutation Test: CLL Drug Resistance Marker and Mutation Meaning

Learn what a BTK mutation test means in CLL, how C481 and other variants cause BTK inhibitor resistance, and how positive or negative results are interpreted.

A BTK mutation test looks for acquired changes in the Bruton tyrosine kinase gene that can help explain resistance to BTK inhibitor treatment in...

CALR Mutation Test: Essential Thrombocythemia, Myelofibrosis, Platelets, and Mutation Meaning

Learn how CALR mutation testing helps diagnose essential thrombocythemia and myelofibrosis, what type 1 and type 2 variants mean, and how results affect risk.

A CALR mutation test looks for acquired mutations in the calreticulin gene that are strongly associated with certain myeloproliferative neoplasms, especially essential thrombocythemia (ET)...

CCND1/IGH Fusion Test: Mantle Cell Lymphoma, Cyclin D1, and FISH Result

Learn how CCND1/IGH FISH detects t(11;14) in mantle cell lymphoma, what positive and negative results mean, and how cyclin D1 and SOX11 support diagnosis.

A CCND1/IGH fusion test looks for the genetic rearrangement created by t(11;14)(q13;q32), the hallmark chromosome abnormality in most mantle cell lymphomas (MCL). The translocation...

CD19 Test: B-Cell Leukemia, Lymphoma, CAR-T Marker, and Positive Staining

Learn what a CD19 test shows in B-cell leukemia and lymphoma, how positive staining is interpreted, and why CD19 matters before and after CAR-T therapy.

A CD19 test checks whether cells express CD19, a surface protein found across most of the B-cell lineage. In hematologic cancer, CD19 is usually...

CD20 Test: B-Cell Lymphoma Marker, B-Cell Lineage, and Positive Staining

Learn what CD20-positive staining means in B-cell lymphoma, how flow cytometry and IHC differ, and why CD20 expression can change after targeted therapy.

A CD20 test checks whether cells express CD20, a surface protein found on most mature B lymphocytes. In lymphoma diagnosis, CD20 is commonly assessed...

CD22 Test: B-Cell Leukemia, Lymphoma Marker, and Positive Staining

Learn what a CD22 test shows in B-cell leukemia and lymphoma, what positive or dim staining means, and how CD22 can affect diagnosis, treatment, and MRD testing.

A CD22 test looks for CD22 protein on or within B cells and is used mainly to help classify B-cell leukemias and lymphomas. CD22...

CD30 Test: Hodgkin Lymphoma, T-Cell Lymphoma, Positive Staining, and Marker Meaning

Understand what a CD30 test means in Hodgkin and T-cell lymphomas, how positive staining is interpreted, and when CD30 expression may affect diagnosis and targeted therapy.

A CD30 test looks for CD30 protein on abnormal lymphoid cells and is especially important in the diagnosis of classic Hodgkin lymphoma and anaplastic...

CD33 Test: AML Marker, Myeloid Blasts, and Positive Staining

Learn what a CD33 test means in AML, how myeloid blast positivity is interpreted, and how CD33 expression can affect leukemia diagnosis, targeted treatment, and MRD follow-up.

A CD33 test checks whether blood or bone marrow cells express CD33, a protein associated mainly with myeloid development. It is commonly included in...

CD34 Test: Leukemia Blast Marker, Stem Cell Marker, and Positive Staining

Understand what a CD34 test means in leukemia and stem cell testing, how positive blast staining is interpreted, and why CD34 alone does not diagnose acute leukemia.

A CD34 test identifies cells that express CD34, a protein found on many early blood-forming stem and progenitor cells and on vascular endothelial cells....

CD38 Test: Myeloma Marker, CLL Marker, and Positive Staining

Learn what a CD38 test means in multiple myeloma and CLL, how positive staining is interpreted, and how anti-CD38 therapy can change flow cytometry and MRD testing.

A CD38 test measures expression of CD38, a surface protein found at very high levels on plasma cells and at variable levels on other...

CD138 Test: Plasma Cell Marker, Myeloma, and Bone Marrow Assessment

Understand what a CD138 test shows in bone marrow, what positive plasma-cell staining means, and how CD138 helps assess multiple myeloma and related disorders.

A CD138 test helps pathologists identify plasma cells in bone marrow or tissue, especially when multiple myeloma or another plasma cell disorder is being...

Chronic Lymphocytic Leukemia (CLL) FISH Panel: del17p, del11q, Trisomy 12, and Prognosis

Understand CLL FISH results for del(17p), del(11q), trisomy 12, and del(13q), including what they mean for TP53 risk, prognosis, repeat testing, and treatment planning.

A CLL FISH panel looks for selected chromosome changes inside chronic lymphocytic leukemia cells. The most familiar targets include deletion 17p, deletion 11q, trisomy...